Targeting PIM kinase as a therapeutic strategy in human hepatoblastomaLaura L. Stafman, Elizabeth A. Beierle|Oncotarget|2018Cited by 30
PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cellsLaura L. Stafman, Elizabeth A. Beierle|PLoS ONE|2019Cited by 15